Bank of Nova Scotia’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-39,430
Closed -$4.98M 1115
2024
Q4
$4.98M Sell
39,430
-142,570
-78% -$21.2M 0.01% 525
2024
Q3
$30.2M Sell
182,000
-20,600
-10% -$3.12M 0.06% 188
2024
Q2
$27M Buy
202,600
+25,155
+14% +$3.03M 0.05% 222
2024
Q1
$18.7M Sell
177,445
-2,900
-2% -$261K 0.04% 282
2023
Q4
$13.6M Buy
+180,345
New +$11.4M 0.03% 358
2023
Q3
Sell
-2,702
Closed -$220K 1059
2023
Q2
$220K Buy
+2,702
New +$192K ﹤0.01% 947
2022
Q4
Sell
-212,000
Closed -$10.9M 1244
2022
Q3
$10.9M Buy
+212,000
New +$12.6M 0.03% 289

Other funds holding THC

Bank of Nova Scotia's THC Position: Q1 2025 in Review

Bank of Nova Scotia sold out of Tenet Healthcare (THC) in Q1 2025, closing a stake of 39,430 shares — an estimated $4.98M sold.

Bank of Nova Scotia first reported a position in THC in Q3 2022 and held it in 7 quarters. The position peaked at $30.2M in Q3 2024. 566 funds tracked by Wall St. Rank hold THC as of Q1 2025.

  • Bank of Nova Scotia reported no remaining Tenet Healthcare position as of Q1 2025 after selling out during the quarter.
  • Bank of Nova Scotia sold 39,430 Tenet Healthcare shares in Q1 2025, an estimated $4.98M.
  • Bank of Nova Scotia first reported a position in Tenet Healthcare in Q3 2022 and held it in 7 quarters.
  • Bank of Nova Scotia's Tenet Healthcare position peaked at $30.2M in Q3 2024.
  • 566 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2025.

Based on Bank of Nova Scotia's 13F filing for Q1 2025, filed 9 May 2025.